All Photos(1)



Dimethyl sulfoxide-d6

99.9 atom % D

Hexadeuterodimethyl sulfoxide, (Methyl sulfoxide)-d6, DMSO-d6
Linear Formula:
CAS Number:
Molecular Weight:
EC Number:
MDL number:
PubChem Substance ID:

vapor pressure

0.42 mmHg ( 20 °C)

isotopic purity

99.9 atom % D


99% (CP)



autoignition temp.

573 °F

expl. lim.

42 %


≤0.0250% water

refractive index

n20/D 1.476 (lit.)


189 °C (lit.)


20.2 °C (lit.)


1.190 g/mL at 25 °C (lit.)

mass shift


SMILES string




InChI key


Looking for similar products? Visit Product Comparison Guide

Related Categories

Certificate of Analysis

Certificate of Origin

Pedro Aqueveque et al.
Zeitschrift fur Naturforschung. C, Journal of biosciences, 70(3-4), 97-102 (2015-05-29)
Liquid fermentations of the fungus Stereum rameale (N° 2511) yielded extracts with antibacterial activity. The antibacterial activity reached its peak after 216 h of stirring. Bioassay-guided fractionation methods were employed for the isolation of the bioactive metabolites. Three known compounds
Nik Khairunissa Nik Abdullah Zawawi et al.
Bioorganic & medicinal chemistry, 23(13), 3119-3125 (2015-05-24)
A library of novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone (3a-3r) was synthesized and evaluated for their potential as β-glucuronidase inhibitors. Several compounds such as 3a-3d, 3e-3j, 3l-3o, 3q and 3r showed excellent inhibitory potentials much better than the standard (IC50=48.4±1.25μM: d-saccharic
Priya P Netalkar et al.
European journal of medicinal chemistry, 79, 47-56 (2014-04-12)
Air and moisture stable coordination compounds of late first row transition metals, viz. Co(II), Ni(II), Cu(II) and Zn(II), with a newly designed ligand, 2-(2-benzo[d]thiazol-2-yl)hydrazono)propan-1-ol (LH), were prepared and successfully characterized using various spectro-analytical techniques. The molecular structures of the ligand
Barbara Parrino et al.
European journal of medicinal chemistry, 94, 367-377 (2015-03-18)
Three new ring systems, pyrido[2',3':3,4]pyrrolo[1,2-a]quinoxalines, pyrido[3',2':3,4]pyrrolo[1,2-a]quinoxalines and pyrido[2',3':5,6]pyrazino[2,1-a]isoindoles, were synthesized through an aza-substitution on the already active isoindolo-quinoxaline system and in particular in the position 7 or 4 of the isoindole moiety and in position 5 of the quinoxaline portion.
Luís Novo et al.
Molecular pharmaceutics, 12(1), 150-161 (2014-11-11)
The applicability of small interfering RNA (siRNA) in future therapies depends on the availability of safe and efficient carrier systems. Ideally, siRNA delivery requires a system that is stable in the circulation but upon specific uptake into target cells can

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service